Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Bill_Enright
|
| gptkbp:collaboratedWith |
gptkb:University_of_Oxford
gptkb:AstraZeneca |
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:developedBy |
gptkb:ChAdOx1_technology
|
| gptkbp:focusesOn |
gptkb:cancer
infectious diseases immunotherapies |
| gptkbp:foundedIn |
2016
|
| gptkbp:founder |
gptkb:Sarah_Gilbert
gptkb:Adrian_Hill |
| gptkbp:headquartersLocation |
gptkb:Oxford,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vaccitech
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:notableFor |
COVID-19 vaccine development
|
| gptkbp:notableProduct |
gptkb:ChAdOx1_nCoV-19_vaccine
|
| gptkbp:platform |
viral vector vaccines
|
| gptkbp:stockSymbol |
gptkb:VACC
|
| gptkbp:website |
https://www.vaccitech.co.uk/
|
| gptkbp:bfsParent |
gptkb:Oxford–AstraZeneca_COVID-19_vaccine
gptkb:Dame_Sarah_Gilbert |
| gptkbp:bfsLayer |
6
|